PNAS:牛磺酸转运蛋白(TauT)缺乏损害肝脏的氨解毒作用

2019-03-14 海北 MedSci原创

研究人员尝试在牛磺酸转运蛋白(TauT)敲除的小鼠中分析肝氨处理情况。令人惊讶的是,尽管组织完整性正常,但在3和12个月时小鼠存在高氨血症。这伴随着脑RNA氧化。

研究人员尝试在牛磺酸转运蛋白(TauT)敲除的小鼠中分析肝氨处理情况。令人惊讶的是,尽管组织完整性正常,但在312个月时小鼠存在高氨血症。这伴随着脑RNA氧化。

如肝脏灌注实验所示,在TauT KO小鼠中氨的谷氨酰胺产生减少,而尿素产生不受影响。在来自3个月大的TauT KO小鼠的肝脏中,蛋白质表达和谷氨酰胺合成酶(GS)的活性未受影响,而氨运输的RhBG蛋白质下调约50%。

谷氨酰胺合成与过量氨浓度的双倒数图分析显示,TauT KO3个月大的小鼠中谷氨酰胺形成的能力没有影响,但是使半数最大谷氨酰胺合成所需的氨浓度加倍。由于肝RhBG表达局限于表达GS的肝细胞,因此研究结果表明,氨转运到这些细胞中会损害谷氨酰胺的合成。

在来自12个月大的TauT KO小鼠的肝脏中,RhBG表达没有受到影响,氧化应激的替代标志物被强烈上调,并且由于酪氨酸硝化失活,GS活性降低了40%。

这也反映在灌注肝脏的动力学分析中,其显示谷氨酰胺合成能力降低43%,并且氨浓度依赖性基本上不受影响。

因此,该研究的结论是,由于在3个月时通过RhBG的氨转运受损以及在12个月大的TauT KO小鼠中GS的酪氨酸硝化依赖性失活,TauT缺乏通过肝谷氨酰胺合成受损引发高氨血症。


原始出处:

Qvartskhava N et al. Taurine transporter (TauT) deficiency impairs ammonia detoxification in mouse liver. PNAS, 2019; doi: 10.1073/pnas.1813100116.


本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1696332, encodeId=b0a21696332ff, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Fri Nov 29 03:16:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856285, encodeId=00d61856285be, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Aug 09 13:16:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486605, encodeId=efa6148660557, content=<a href='/topic/show?id=28376e774e0' target=_blank style='color:#2F92EE;'>#牛磺酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67774, encryptionId=28376e774e0, topicName=牛磺酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27f8182618, createdName=gj0734, createdTime=Sat Mar 16 10:16:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509274, encodeId=bb5215092e434, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17144, encryptionId=19791e14471, topicName=Tau)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c610090940, createdName=szhvet, createdTime=Sat Mar 16 10:16:00 CST 2019, time=2019-03-16, status=1, ipAttribution=)]
    2019-11-29 yzh409
  2. [GetPortalCommentsPageByObjectIdResponse(id=1696332, encodeId=b0a21696332ff, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Fri Nov 29 03:16:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856285, encodeId=00d61856285be, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Aug 09 13:16:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486605, encodeId=efa6148660557, content=<a href='/topic/show?id=28376e774e0' target=_blank style='color:#2F92EE;'>#牛磺酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67774, encryptionId=28376e774e0, topicName=牛磺酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27f8182618, createdName=gj0734, createdTime=Sat Mar 16 10:16:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509274, encodeId=bb5215092e434, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17144, encryptionId=19791e14471, topicName=Tau)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c610090940, createdName=szhvet, createdTime=Sat Mar 16 10:16:00 CST 2019, time=2019-03-16, status=1, ipAttribution=)]
    2019-08-09 drwjr
  3. [GetPortalCommentsPageByObjectIdResponse(id=1696332, encodeId=b0a21696332ff, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Fri Nov 29 03:16:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856285, encodeId=00d61856285be, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Aug 09 13:16:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486605, encodeId=efa6148660557, content=<a href='/topic/show?id=28376e774e0' target=_blank style='color:#2F92EE;'>#牛磺酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67774, encryptionId=28376e774e0, topicName=牛磺酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27f8182618, createdName=gj0734, createdTime=Sat Mar 16 10:16:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509274, encodeId=bb5215092e434, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17144, encryptionId=19791e14471, topicName=Tau)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c610090940, createdName=szhvet, createdTime=Sat Mar 16 10:16:00 CST 2019, time=2019-03-16, status=1, ipAttribution=)]
    2019-03-16 gj0734
  4. [GetPortalCommentsPageByObjectIdResponse(id=1696332, encodeId=b0a21696332ff, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Fri Nov 29 03:16:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856285, encodeId=00d61856285be, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Aug 09 13:16:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486605, encodeId=efa6148660557, content=<a href='/topic/show?id=28376e774e0' target=_blank style='color:#2F92EE;'>#牛磺酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67774, encryptionId=28376e774e0, topicName=牛磺酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27f8182618, createdName=gj0734, createdTime=Sat Mar 16 10:16:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509274, encodeId=bb5215092e434, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17144, encryptionId=19791e14471, topicName=Tau)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c610090940, createdName=szhvet, createdTime=Sat Mar 16 10:16:00 CST 2019, time=2019-03-16, status=1, ipAttribution=)]
    2019-03-16 szhvet

相关资讯

肝脏肿瘤误诊病例不典型肝癌1例

患者,男,37岁,因发现肝脏占位性病变1月入院。患者于1个月前起感间断上腹部隐痛不适,在当地医院行肝胆超声检查提示肝脏右叶占位性病变。查体:皮肤巩膜无黄染,浅表淋巴结不肿大;全腹无包块,无压痛,肝脾肋下未触及。血常规、生化指标全项均在正常范围,各型肝炎标志物及AFP均阴性。

Gastroenterology:晚期肝硬化长期使用诺氟沙星或可降低死亡率,且不会增加多重耐药菌感染的几率

近日,法国18家临床中心共同完成的一项随机对照研究(NORFLOCIR)表明:晚期肝硬化患者接受氟喹诺酮类药物诺氟沙星长期治疗,6个月生存率虽未得到显着提升,但诺氟沙星似乎可以增加腹水蛋白水平较低者的生存率,且可预防感染发生。

Nature:科学家揭示癌症常扩散到肝脏的原因

当癌细胞扩散至另一个器官时,最常见的是转移到肝脏。是何缘由?宾夕法尼亚大学的研究人员给出了的答案。近日,发表在《Nature》杂志上的一项新研究表明,肝细胞(作为肝脏主要功能细胞)处于一个连锁反应的中心,这使得肝脏特别容易受到癌细胞的影响。

Immunity:科学家发现自然杀伤细胞如何影响肝脏免疫功能

中国科大生命科学与医学部田志刚课题组发现,肝脏中存在一群能负调T细胞抗病毒免疫应答的特殊NK细胞,并揭示了其功能发挥的机制。相关成果日前发表于《细胞》出版集团旗下《免疫》杂志。

Cell Rep:研究发现2型糖尿病易感基因突变的致病机制

该研究发现SLC16A11基因编码区的2型糖尿病易感突变会产生功能获得性突变蛋白,导致肝脏脂滴不正常积累增多,进而导致2型糖尿病的发生。该研究结果对之前报道的认为此类易感突变导致蛋白功能缺失的研究结论提出了质疑。

超声造影及增强CT诊断肝脏血管周上皮样肿瘤1例

患者女,49岁,汉族,已婚,农民。以3d前右下肢出现大片状红斑到我院皮肤科就诊收住入院。体格检查:无明显异常。实验室检查:肿瘤标记物CA72413.6U/ml,其余阴性。超声检查:肝左叶见大小约61mm×56mm实性略高回声占位,边界清晰,内部回声不均匀,CDFI:肿块周边及内部见较丰富血流信号。超声造影:造影剂注入肿块后9s呈环状且向心性轮辐样高增强,10s迅速强化,30s逐渐消退,肿块边界清晰